Potential early biomarker to track development of non-alcoholic fatty liver disease

(Joslin Diabetes Center) Research from Rohit N. Kulkarni's lab at Joslin Diabetes Center has uncovered a biomarker in humans tied to the development of Non-Alcoholic Fatty Liver Disease that might help doctors detect early stages of the disease. The researchers also determined that this biomarker, a protein known as 'neuronal regeneration related protein' (or NREP), plays a significant role in the regulation of a pathway that is currently being reviewed in clinical trials as a treatment option for the disease.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news